Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2015

Open Access 01-12-2015 | Case report

Neonatal McCune–Albright syndrome with systemic involvement: a case report

Authors: Rita Lourenço, Patrícia Dias, Raquel Gouveia, Ana Berta Sousa, Graça Oliveira

Published in: Journal of Medical Case Reports | Issue 1/2015

Login to get access

Abstract

Introduction

McCune–Albright syndrome is a rare sporadic disease characterized by fibrous bone dysplasia, café-au-lait skin spots and variable hyperfunctional endocrinopathies. McCune–Albright syndrome is caused by somatic postzygotic activating mutations in the GNAS gene that produce a broad spectrum of effects.

Case presentation

We report a case of McCune–Albright syndrome with multi-organ manifestations in the neonatal period. A newborn preterm black girl was referred to our Neonatal Intensive Care Unit at the age of 17 days for suspected extrahepatic cholestasis. On clinical examination she presented failure to thrive, jaundice, hypertension, marked hypotonia and café-au-lait spots on her back and lower limbs. An abdominal ultrasound excluded extrahepatic causes of cholestasis but revealed bilateral serpiginous adrenal hyperplasia. These clinical findings suggested a diagnosis of McCune–Albright syndrome with multi-organ involvement. Laboratory data confirmed adrenocorticotropic hormone-independent Cushing’s syndrome, hyperthyroidism, cholestasis and elevated transaminases. Ventricular hypertrophy was demonstrated by echocardiography. The baby girl underwent medical treatment of Cushing’s syndrome with metyrapone which was followed by a rapid recovery. A mosaic activating GNAS gene mutation was found on DNA extracted from a buccal swab sample. However, she died at 4 months due to a respiratory infection.

Conclusion

In the neonatal period the diagnosis of McCune–Albright syndrome depends on having a high index of suspicion and café-au-lait spots may be the clue for the diagnosis.
Literature
1.
go back to reference Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females. N Eng J Med. 1937;216:727–46.CrossRef Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females. N Eng J Med. 1937;216:727–46.CrossRef
3.
go back to reference Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N Engl J Med. 1991;325:1688–95.CrossRefPubMed Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N Engl J Med. 1991;325:1688–95.CrossRefPubMed
4.
go back to reference Happle R. The McCune–Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet. 1986;29:321–4.CrossRefPubMed Happle R. The McCune–Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet. 1986;29:321–4.CrossRefPubMed
5.
go back to reference Kirk JM, Brain CE, Carson DJ, Hyde JC, Grant DB. Cushing’s syndrome caused by nodular adrenal hyperplasia in children with McCune–Albright syndrome. J Pediatr. 1999;134:789–92.CrossRefPubMed Kirk JM, Brain CE, Carson DJ, Hyde JC, Grant DB. Cushing’s syndrome caused by nodular adrenal hyperplasia in children with McCune–Albright syndrome. J Pediatr. 1999;134:789–92.CrossRefPubMed
7.
go back to reference Collins MT, Singer FR, Eugster E. McCune–Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis. 2012;7 Suppl 1:S4. Epub 2012 May.CrossRefPubMedPubMedCentral Collins MT, Singer FR, Eugster E. McCune–Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis. 2012;7 Suppl 1:S4. Epub 2012 May.CrossRefPubMedPubMedCentral
8.
go back to reference Combest WL, Russell DH. Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat. Mol Pharmacol. 1983;23:641–7.PubMed Combest WL, Russell DH. Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat. Mol Pharmacol. 1983;23:641–7.PubMed
9.
go back to reference Celi FS, Coppotelli G, Chidakel A, Kelly M, Brillante BA, Shawker T, et al. The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3' triiodothyronine toxicosis of McCune–Albright syndrome. J Clin Endocrinol Metab. 2008;93:2383–9.CrossRefPubMedPubMedCentral Celi FS, Coppotelli G, Chidakel A, Kelly M, Brillante BA, Shawker T, et al. The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3' triiodothyronine toxicosis of McCune–Albright syndrome. J Clin Endocrinol Metab. 2008;93:2383–9.CrossRefPubMedPubMedCentral
10.
go back to reference Collins MT, Sarlis NJ, Merino MJ, Monroe J, Crawford SE, Krakoff JA, et al. Thyroid carcinoma in the McCune–Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab. 2003;88:4413–7.CrossRefPubMed Collins MT, Sarlis NJ, Merino MJ, Monroe J, Crawford SE, Krakoff JA, et al. Thyroid carcinoma in the McCune–Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab. 2003;88:4413–7.CrossRefPubMed
11.
go back to reference Yoshimoto M, Nakayama M, Baba T, Uehara Y, Niikawa N, Ito M, et al. A case of neonatal McCune–Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Paediatr Scand. 1991;80:984–7.CrossRefPubMed Yoshimoto M, Nakayama M, Baba T, Uehara Y, Niikawa N, Ito M, et al. A case of neonatal McCune–Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Paediatr Scand. 1991;80:984–7.CrossRefPubMed
12.
go back to reference Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, et al. Severe endocrine and nonendocrine manifestations of the McCune–Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr. 1993;123(4):509–18.CrossRefPubMed Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, et al. Severe endocrine and nonendocrine manifestations of the McCune–Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr. 1993;123(4):509–18.CrossRefPubMed
13.
go back to reference Davies JH, Barton JS, Gregory JW, Mills C. Infantile McCune–Albright syndrome. Pediatr Dermatol. 2001;18:504–6.CrossRefPubMed Davies JH, Barton JS, Gregory JW, Mills C. Infantile McCune–Albright syndrome. Pediatr Dermatol. 2001;18:504–6.CrossRefPubMed
14.
go back to reference Silva ES, Lumbroso S, Medina M, Gillerot Y, Sultan C, Sokal EM. Demonstration of McCune–Albright mutations in the liver of children with high gammaGT progressive cholestasis. J Hepatol. 2000;32:154–8.CrossRefPubMed Silva ES, Lumbroso S, Medina M, Gillerot Y, Sultan C, Sokal EM. Demonstration of McCune–Albright mutations in the liver of children with high gammaGT progressive cholestasis. J Hepatol. 2000;32:154–8.CrossRefPubMed
Metadata
Title
Neonatal McCune–Albright syndrome with systemic involvement: a case report
Authors
Rita Lourenço
Patrícia Dias
Raquel Gouveia
Ana Berta Sousa
Graça Oliveira
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2015
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-015-0689-2

Other articles of this Issue 1/2015

Journal of Medical Case Reports 1/2015 Go to the issue